Shenzhen Mingyi Zhizao Technology Co., Ltd, a Chinese company specializing in the gene sequencing industry, has reportedly secured nearly RMB 100 million (USD 14 million) in a Series B++ funding round led by Tenykin Capital and Jiangsu Jinqiao Private Equity Fund. The fresh capital is earmarked for the expansion of the company’s gene sequencing platform manufacturing capabilities, mass production of sequencers, development of a market promotion network, and regulatory filings for its sequencing devices.
Established in 2018, Mingyi Zhizao concentrates on the research, development, and manufacturing of upstream equipment and reagents for gene sequencing. The company has launched the UniSeq2000, a world-leading monochromatic fluorescent gene sequencer. The desktop NGS sequencer is designed for clinical applications and integrates microfluidic chip technology with proprietary monochromatic fluorescence sequencing chemistry. Capable of simultaneous synthesis and sequencing, it enables gene sequencing across various scientific and clinical samples, offering high accuracy, flexible throughput, ease of operation, and controllable sequencing costs.- Flcube.com
